Skip to content

Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis

Comparing the Effectiveness of Steroid Injection Versus Placebo and Immobilization Versus no Immobilization in Treating Patients With Lateral Epicondylitis

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01986465
Enrollment
78
Registered
2013-11-18
Start date
2013-05-31
Completion date
2013-11-30
Last updated
2013-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral Epicondylitis

Keywords

lateral epicondylitis, treatment, steroid, immobilization

Brief summary

The aim of this study is to evaluate the effectiveness of steroid injection and immobilization versus no immobilization in treating patients with lateral epicondylitis.

Interventions

DRUGPlacebo

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18 to 65 years * confirmed lateral epicondylitis * had not received any treatment prior to enrolment

Exclusion criteria

* symptoms lasting less than 6 weeks * history of acute trauma, fracture, and/or surgery within 12 months * patients who had received corticosteroid injection, physiotherapy, splint or casting during the past 6 months * bilateral involvement and history of cervical disk herniation, radiculopathy or abnormal electrophysiologic study

Design outcomes

Primary

MeasureTime frameDescription
FunctionWithin the first 24 weeks after therapyThe trial subjects are evaluated using the Oxford Elbow Scale (OES). They are asked to come to the trial office at 2 weeks, 4 weeks and 24 weeks for follow-up evaluation by administration of OES.
PainWithin the first 24 weeks after therapyThe trial subjects are evaluated using the Oxford Elbow Scale (OES). They are asked to come to the trial office at 2 weeks, 4 weeks and 24 weeks for follow-up evaluation by administration of OES.
Social-psychologicalWithin the first 24 weeks after therapyThe trial subjects are evaluated using the Oxford Elbow Scale (OES). They are asked to come to the trial office at 2 weeks, 4 weeks and 24 weeks for follow-up evaluation by administration of OES.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026